Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

HPV8 E6 gene causes growth of certain skin stem cells.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

Lower SMAD2/3 activation predicts more severe skin cancer.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Lrig1 and Lgr6 stem cells help maintain hair follicles and influence skin cancer development.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Finding a positive nonsentinel lymph node in melanoma patients indicates a worse prognosis.

Researchers found three types of melanocytes in developing mouse skin, each with different genes and locations.

Surgery and antifungal medication are effective for treating Merkel cell carcinoma with fungal infection.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Bcl-2 helps hair regeneration but can also increase cancer risk.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Keratinocyte-expressed podoplanin is not needed for starting skin cancer but helps tumor progression.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

An automated system can predict death risk in thin melanoma by analyzing immune cells.